The Emergence of the Randomized, Controlled Trial

This historical perspective traces the development of the randomized controlled trial from ancient comparative experiments through its formalization in the mid-20th century, arguing that the 1948 MRC streptomycin trial was part of a much longer evolution rather than a singular breakthrough. The authors show how intellectual, social, and regulatory forces shaped both the adoption of and resistance to controlled trials as a medical research standard.